Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 67

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 67
---
 recorded in the nine months period ended September 30, 2025 compared with the same period in 2024.

General and Administrative Expenses

Successor’s general and administrative
expenses totaled $1,423 thousand for the nine months period ended September 30, 2025, representing an increase of $702 thousand, or 197.3%,
compared to Predecessor’s and Successors’ combined $721 thousand for the same period. General and administrative expenses comprise
mainly from salaries and related expenses, share based payment expenses, professional services and other expenses. The increase was primarily
attributable to higher share-based payment expense, Successor’s salaries and related expenses and Successor’s professional
services for such period compared with the same period in 2024.

Operating Loss

As a result of the foregoing, Successor’s
operating loss totaled $2,258 thousand for the nine months period ended September 30, 2025, representing an increase of $44 thousand,
or 1.9%, compared to Predecessor’s and Successors’ combined $2,214 thousand loss for the same period.

Financing income, Net

Successor recognized financing income, net
of $68 thousand for the nine months period ended September 30, 2025, representing an increase of $45 thousand, or 195.6%, compared to
Predecessor’s and Successors’ combined $23 thousand for the same period. The increase in finance income, net was primarily attributable
to Successor’s interest income from short term deposits and higher exchange rate differences expense between the U.S. dollar and
the New Israeli Shekel.

Net and Comprehensive Loss

As a result of the foregoing, Successor’s
loss totaled $2,190 thousand for the nine months period ended September 30, 2025, representing a decrease of $1 thousand, or 0.0%, compared
to Predecessor’s and Successors’ combined $2,191 thousand for the same period.

<div align='center'>39</div>

Successor for the period from July 24, 2024 through December 31, 2024, the Predecessor period from January 1, 2024 through July 23, 2024, and for the year ended December 31, 2023

The following tables present selected financial
data for the Successor period from July 24, 2024 through December 31, 2024, the Predecessor period